InvestorsHub Logo
Followers 73
Posts 6214
Boards Moderated 0
Alias Born 05/01/2011

Re: couldbebetter post# 152483

Thursday, 10/25/2018 4:09:44 PM

Thursday, October 25, 2018 4:09:44 PM

Post# of 426538
I'm a huge fan of the performance of this management team, from the AdCom debacle until right now.

But I have to admit -- I'm not sure trying to turn AMRN into a Big Pharma with a diversified pipeline makes a lot of sense.

Expanding Vascepa, and Vascepa cousins, as far as possible? Sure. Getting into whole new product lines? Not so much.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News